Fred Hutchinson Cancer Research Center (Seattle) begins Ceprate trial:
This article was originally published in Clinica
Executive Summary
The Fred Hutchinson Cancer Research Center (Seattle) has begun a pilot clinical trial of CellPro's stem cell separation system, Ceprate SC, in chronic lymphocytic leukaemia. The system is already in Phase II trials in multiple myeloma patients at 15 sites throughout North America (see Clinica No 638, p 19).